Reconstituted solutions remain stable for approximately 2-3 weeks under these conditions
Secondary outcome measurements included reduction in body weight from baseline by at least 5% or 10% by week 26, changes in waist circumference, total cholesterol, HDL, LDL, VLDL, and triglycerides, and levels of different glycemic variables including HbA1C, fasting plasma glucose, fasting insulin, insulin resistance, and the functioning of beta-cells
While most of these studies are preliminary, they have shown promising results
They act on different cellular components, through different signaling logic, and with different kinetic profiles
Q: When should someone use this injectable combination rather than oral supplements
Internal stability improves under a reinforced lining structure